Stockreport

Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron Paris – April 6, 2020 – Sanofi has finalized the planned restructuring related to Praluent® (aliroc [Read more]